Form D · Pharmaceuticals
Farm to Farma, Inc.
Incline Village, NV · CIK 0001719641
Offering snapshot reported Nov 9, 2017 · SEC filing
- Reported sold
- $0 Offering amount: $1.5M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 11, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 9, 2017 | Initial | $0 | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-298444
Source: Form D, filed Nov 9, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Andrew Caplan | Director |
| Lezlie A Colburn | Executive |
| Shane Johnson | Director, Executive, Promoter |
| John M Sutton | Director |
| Ronald B Verstappen | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
930 Tahoe Blvd., Suite 802 433
Incline Village, NV, 89451
Incline Village, NV, 89451